Angela R. Omilian
Buffalo State University, Roswell Park Comprehensive Cancer Center
Papers
2
Total Citations
36
H-Index
2
About
Angela R. Omilian is a cancer biologist whose research focuses on the epigenetic mechanisms driving tumor progression, with a particular emphasis on the tumor microenvironment and prostate cancer. Her most cited work investigates how DNA methylation—specifically of the *CYP24A1* gene promoter—differs in endothelial cells isolated from benign versus malignant prostate tissue, revealing that epigenetic alterations in tumor-associated vasculature may play a critical role in cancer development and progression. This foundational study, published in 2011 and garnering 32 citations, highlights her contribution to understanding how the microenvironment's epigenetic landscape influences malignancy. Omilian also addresses the practical challenges of cancer research, as seen in her 2015 study on the impact of devascularization and tissue procurement methods on RNA integrity in prostatectomy samples. This work underscores her commitment to improving experimental rigor in translational studies. Through her research, Omilian bridges molecular epigenetics and clinical tissue handling, providing insights that are valuable for both basic scientists and clinicians working to unravel the complexities of prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2